| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 143, 1366-1376, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
JL Barnes and HE Abboud
Department of Medicine, University of Texas Health Science Center, San Antonio 78284.
Habu snake venom induces an accelerated mesangial proliferative glomerulonephritis that follows a predictable course from early capillary aneurysms to micronodules comprised of confluent mesangial cells within 72 hours. We examined morphologically the course of mesangial cell proliferation and correlated it with the expression of messenger (m) RNA encoding two peptide growth factors, platelet-derived growth factor (PDGF) A and B chains and transforming growth factor-beta (TGF-beta). Rats were uninephrectomized and 24 hours later injected with Habu snake venom or saline. Kidney cortex and isolated glomeruli were obtained 24, 48, and 72 hours later for histological assessment, preparation and Northern analysis of mRNA, and immunohistochemical localization of PDGF using a polyclonal antibody that recognizes A and B chains. Maximal expression of PDGF B chain mRNA occurred at 24 hours and before the onset of mesangial cell proliferation; whereas maximal expression of PDGF A chain and TGF-beta mRNA occurred at 48 hours and during active mesangial cell proliferation. Expression of TGF-beta mRNA persisted at 72 hours at a time when PDGF A chain declined and PDGF B chain was not expressed compared to uninephrectomy and saline controls and at a time when mesangial cells within lesions reached confluence and proliferation subsided. PDGF protein localized in glomerular lesions associated with platelets at 24 and 48 hours and within mesangial cells at 48 and 72 hours. These results agree with the known roles of PDGF and TGF-beta as positive and negative modulators, respectively, of mesangial cell growth in vitro and suggest that a relative balance of the expression of these factors may operate in glomerular disease in vivo.
This article has been cited by other articles:
 |
|
 |
|
  J. Floege, F. Eitner, and C. E. Alpers A New Look at Platelet-Derived Growth Factor in Renal Disease J. Am. Soc. Nephrol., January 1, 2008; 19(1): 12 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Faulkner, L. M. Szcykalski, F. Springer, and J. L. Barnes Origin of Interstitial Fibroblasts in an Accelerated Model of Angiotensin II-Induced Renal Fibrosis Am. J. Pathol., November 1, 2005; 167(5): 1193 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huard, Y. Li, and F. H. Fu Muscle Injuries and Repair: Current Trends in Research J. Bone Joint Surg. Am., May 1, 2002; 84(5): 822 - 832. [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Barnes, J. Musa, R. J. Mitchell, and J. L. Barnes Expression of Embryonic Fibronectin Isoform EIIIA Parallels {alpha}-Smooth Muscle Actin in Maturing and Diseased Kidney J. Histochem. Cytochem., June 1, 1999; 47(6): 787 - 798. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Barnes, R. J. Mitchell, J. J. Kanalas, and V. L. Barnes Differential Expression of Thrombospondin and Cellular Fibronectin During Remodeling in Proliferative Glomerulonephritis J. Histochem. Cytochem., April 1, 1999; 47(4): 533 - 544. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Simon, J. G. Maresh, S. E. Harris, J. D. Hernandez, M. Arar, M. S. Olson, and H. E. Abboud Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney Am J Physiol Renal Physiol, March 1, 1999; 276(3): F382 - F389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Border and N. A. Noble Transforming Growth Factor {beta} in Tissue Fibrosis N. Engl. J. Med., November 10, 1994; 331(19): 1286 - 1292. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
